|
| Exchange Disseminated Time 24/10/2018 15:43:46 | Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on November 01, 2018 inter alia, to consider and approve, the:
1. Un-audited Financial Results along with the Limited Review Report for the quarter ended September 30, 2018.
2. Declaration of First Interim Dividend for the Financial Year 2018-19
In view of the above, as per the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company's Code of Conduct to regulate, monitor and report trading by insiders, the trading window for dealing in the securities of the Company shall remain closed for the Specified Persons (Promoters, Directors, Designated Employees, etc.) from October 25, 2018 to November 04, 2018 (both days inclusive). |
|
|